LAUSR

Coronary artery disease (CAD) is one of the leading causes of death worldwide; however, a therapeutic remedy has not been developed. Coronary angiogenesis, a process by which new coronary vessels are formed in the embryos, is primarily a function of endothelial cells which form the inner lining of the vessel wall. Therefore, understanding coronary endothelial cells' cellular and molecular biology can teach us how to effectively stimulate the repair and regeneration of damaged coronary vessels. Investigations in mice have identified the Apelin receptor (alias: APJ) and Vascular endothelial growth factor receptor 2 (VEGFR2) signaling as regulators of coronary angiogenesis. However, it is unclear whether APJ and VEGFR2 signaling interact with one another in the regulation of coronary angiogenesis. To investigate this, we performed in vitro cell culture experiments using isolated coronary endothelial cells and in vivo experiments with APJ KO mice. We hypothesize that ELABELA/APJ signaling downregulates VEGFR2 expression in coronary endothelial cells. Our expression analysis using immunostaining and qPCR show that APJ loss-of-function in coronary endothelial cells results in increased VEGFR2 expression. Collectively, our results show that ELABELA/APJ suppresses VEGFR2 signaling during coronary angiogenesis. This study is supported by the NIH R15 (1R15HL159660-01) research grant to BS. This is the full abstract presented at the American Physiology Summit 2023 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.